Back to search
Choroidal Melanoma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Choroidal Melanoma trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Choroidal Melanoma trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is a Phase 3, randomized, multi-center, open-label study of neoadjuvant darovasertib in subjects with primary non-metastatic uveal melanoma (OptimUM-10)
The primary objective is to determine the safety and efficacy of belzupacap sarotalocan (bel-sar) compared to sham control in patients with primary indeterminat…
To assess subject-centric real-world evidence of QoL outcomes in subjects enrolled in the global Phase 3 AU-011-301 clinical trial.
This study is being done to find the best dose of an investigational drug called NBM-BMX for people with metastatic uveal melanoma, a type of eye cancer that ha…
Ocular melanomas have been treated for a long time by enucleation, with an unfavorable major impact on the patient's quality of life, social life, self-image, h…
The purpose of this observational research study is to follow participants who have been treated with bel-sar while participating in a previous Aura Biosciences…